
Panelists challenge the belief that testosterone fuels prostate cancer, explain PSA on therapy and TRAVERSE BPH data, and weigh Schedule III status.
Las Vegas--Urologists are beginning to use a more extensive biopsyregimen when working up men with suspected prostate cancer. Although thisis paying off in increased disease detection, it also has raised questionsabout whether some men are being over-treated for clinically insignificantdisease.





